0001179110-13-011353.txt : 20130702 0001179110-13-011353.hdr.sgml : 20130702 20130702185333 ACCESSION NUMBER: 0001179110-13-011353 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130701 FILED AS OF DATE: 20130702 DATE AS OF CHANGE: 20130702 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ONYX PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001012140 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943154463 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 249 E. GRAND AVE. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-266-0000 MAIL ADDRESS: STREET 1: 249 E. GRAND AVE. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GODDARD PAUL CENTRAL INDEX KEY: 0001227124 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-28298 FILM NUMBER: 13950413 MAIL ADDRESS: STREET 1: ADOLOR CORPORATION STREET 2: 700 PENNSYLVANIA DR. CITY: EXTON STATE: PA ZIP: 19341 4 1 edgar.xml FORM 4 - X0306 4 2013-07-01 0 0001012140 ONYX PHARMACEUTICALS INC ONXX 0001227124 GODDARD PAUL C/O ONYX PHARMACEUTICALS, INC. 249 E. GRAND AVE. SOUTH SAN FRANCISCO CA 94080 1 0 0 0 Common Stock 2013-07-01 4 M 0 2000 12.50 A 16890 D Common Stock 2013-07-01 4 M 0 4000 28.41 A 20890 D Common Stock 2013-07-01 4 S 0 3500 131.9151 D 17390 D Common Stock 2013-07-01 4 S 0 2500 132.63 D 14890 D Stock Option (Right to Buy) 28.41 2013-07-01 4 M 0 4000 0.00 D 2015-02-07 Common Stock 4000 1000 D Stock Option (Right to Buy) 12.50 2013-07-01 4 M 0 2000 0.00 D 2017-02-07 Common Stock 2000 0 D Shares sold pursuant to 10b5-1 plan. The shares were sold at prices ranging from $131.58 to $132.425. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Fully vested. /s/ Warren DeSouza, Attorney-In-Fact 2013-07-02